278 related articles for article (PubMed ID: 34443437)
1. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target.
Alain C; Pascal N; Valérie G; Thierry V
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443437
[TBL] [Abstract][Full Text] [Related]
2. The Orexin receptors: Structural and anti-tumoral properties.
Couvineau A; Nicole P; Gratio V; Voisin T
Front Endocrinol (Lausanne); 2022; 13():931970. PubMed ID: 35966051
[TBL] [Abstract][Full Text] [Related]
3. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
Xu TR; Yang Y; Ward R; Gao L; Liu Y
Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
[TBL] [Abstract][Full Text] [Related]
4. The effect of estrone and estradiol on the expression of the orexin/hypocretin system in the porcine uterus during early pregnancy.
Kiezun M; Dobrzyn K; Rytelewska E; Kisielewska K; Gudelska M; Szeszko K; Zaobidna E; Bors K; Wyrebek J; Mykytiuk A; Kaminski T; Smolinska N
Domest Anim Endocrinol; 2019 Jul; 68():11-24. PubMed ID: 30784944
[TBL] [Abstract][Full Text] [Related]
5. Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives.
Costagliola A; Lombardi R; Liguori G; Morrione A; Giordano A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):637-645. PubMed ID: 38035703
[TBL] [Abstract][Full Text] [Related]
6. The role of the orexin (hypocretin) system in controlling energy homeostasis, endocrine system, and reproduction in pigs and other living organisms.
Wojciechowicz T; Rybska M; Smolinska N; Kaminski T; Rak A; Wlodarek J; Nowak KW; Skrzypski M
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345440
[TBL] [Abstract][Full Text] [Related]
7. Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies.
Ten-Blanco M; Flores Á; Cristino L; Pereda-Pérez I; Berrendero F
Front Neuroendocrinol; 2023 Apr; 69():101066. PubMed ID: 37015302
[TBL] [Abstract][Full Text] [Related]
8. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
9. The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role.
Couvineau A; Dayot S; Nicole P; Gratio V; Rebours V; Couvelard A; Voisin T
Front Endocrinol (Lausanne); 2018; 9():573. PubMed ID: 30319552
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.
Messal N; Fernandez N; Dayot S; Gratio V; Nicole P; Prochasson C; Chantret I; LeGuilloux G; Jarry A; Couvelard A; Tréton X; Voisin T; Ogier-Denis E; Couvineau A
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3618-3628. PubMed ID: 30251681
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus.
Li TL; Chen JYS; Huang SC; Dai YE; Hwang LL
Eur J Pharmacol; 2018 Jan; 818():343-350. PubMed ID: 29104046
[TBL] [Abstract][Full Text] [Related]
12. Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions.
Couvineau A; Voisin T; Nicole P; Gratio V; Blais A
World J Gastroenterol; 2021 Nov; 27(44):7582-7596. PubMed ID: 34908800
[TBL] [Abstract][Full Text] [Related]
13. Expression of the orexin system in the porcine uterus, conceptus and trophoblast during early pregnancy.
Smolinska N; Kiezun M; Dobrzyn K; Szeszko K; Maleszka A; Kaminski T
Animal; 2015 Nov; 9(11):1820-31. PubMed ID: 26133101
[TBL] [Abstract][Full Text] [Related]
14. Effect of orexin A on apoptosis in BGC-823 gastric cancer cells via OX1R through the AKT signaling pathway.
Wen J; Zhao Y; Shen Y; Guo L
Mol Med Rep; 2015 May; 11(5):3439-44. PubMed ID: 25586545
[TBL] [Abstract][Full Text] [Related]
15. Potential role of orexin A binding the receptor 1 for orexins in normal and cryptorchid dogs.
Liguori G; Squillacioti C; Assisi L; Pelagalli A; Vittoria A; Costagliola A; Mirabella N
BMC Vet Res; 2018 Feb; 14(1):55. PubMed ID: 29482574
[TBL] [Abstract][Full Text] [Related]
16. Localization of orexin B and orexin-2 receptor in the rat epididymis.
Liguori G; Tafuri S; Miyoshi C; Yanagisawa M; Squillacioti C; De Pasquale V; Mirabella N; Vittoria A; Costagliola A
Acta Histochem; 2018 Apr; 120(3):292-297. PubMed ID: 29496265
[TBL] [Abstract][Full Text] [Related]
17. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases.
Couvineau A; Voisin T; Nicole P; Gratio V; Abad C; Tan YV
Front Endocrinol (Lausanne); 2019; 10():709. PubMed ID: 31695678
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation.
Vitale RM; Iannotti FA; Schiano Moriello A; Tunisi L; Piscitelli F; Savopoulos R; Cristino L; De Petrocellis L; Amodeo P; Gray R; Di Marzo V
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439801
[TBL] [Abstract][Full Text] [Related]
19. Implicating the potential role of orexin in hypertension.
Rani M; Kumar R; Krishan P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jul; 390(7):667-676. PubMed ID: 28509114
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Hypocretins/Orexins.
López M; de Lecea L; Diéguez C
Front Endocrinol (Lausanne); 2020; 11():357. PubMed ID: 32582031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
